Disparities in Osteoporosis Care among Postmenopausal Women in the United States.

Citation:

Karina N Ruiz-Estevesa, Jimmitti Teysira, Daria Schatoffa, Elaine W Yu, and Sherri-Ann M Burnett-Bowie. 2022. “Disparities in Osteoporosis Care among Postmenopausal Women in the United States.” Maturitas. Copy at https://tinyurl.com/yafnnbo4

Abstract:

Osteoporosis and fragility fractures result in significant morbidity and mortality and contribute to substantial healthcare costs. Despite being a treatable disease, osteoporosis remains both underdiagnosed and undertreated in the US general population, with significant disparities in care between non-White and White women. These disparities are evident from screening to post-fracture treatment. Non-White women are less likely to be screened for osteoporosis, to be prescribed pharmacotherapy, or to receive treatment post-fracture; furthermore, the mortality rate after fracture is higher in non-White women. Given existing diagnostic and treatment disparities, additional studies and interventions are needed to optimize the bone health of Asian, Black, Hispanic, and Native American women, and to reduce morbidity and mortality from osteoporosis and fragility fractures.